CRO recognized for its company culture and flexible work environment
CRO recognized for its company culture and flexible work environment
Chapel Hill, NC – September 11, 2018 -- Rho, a full-service contract research organization (CRO) focused on bringing new products to market through a full range of product development services, announced today that the Triangle Business Journal has ranked the company as the number one extra-large company. The award is part of the publication’s annual Best Places to Work Awards program and recognizes Rho’s achievements in creating a positive work environment that attracts and retains employees through a combination of benefits, working conditions and company culture. It is the seventh year in a row the Chapel-Hill based company has received this recognition.
“We are honored to be recognized once again for the supportive, flexible, and fun work environment we provide Rho’s more than 400 employees,” said Laura Helms Reece, Dr.P.H., chief executive officer at Rho. “For more than 30 years, we have strived to provide challenging and rewarding work to our employees in an environment where they can grow in their professional and personal lives.”
The awards are presented based upon results of employee surveys conducted by the Triangle Business Journal. Rho, along with 50 other local companies, will be recognized during a special award ceremony on Friday, September 7, at Raleigh’s PNC Arena. This is the seventh time that Rho has been awarded the ‘Best Places to Work’ accolade. The CRO has won every year since 2012.
To learn more about Rho, please visit www.rhoworld.com.
About Rho
Rho, a privately-held, contract research organization (CRO) located in Chapel Hill, NC, provides a full range of clinical research services across the entire drug development process. For more than 34 years, Rho has been a trusted partner to some of the industry’s leading pharmaceutical, biotechnology, and medical device companies as well as academic and government organizations. Our commitment to excellence, our innovative technologies, and our therapeutic expertise accelerate time to market, maximize returns on investment, and lead to an exceptional customer experience. Please follow us on Twitter.
